{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:42:38Z","timestamp":1792014158856,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["heartrhythmopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm O2"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.hroo.2021.09.009","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T03:04:44Z","timestamp":1639710284000},"page":"724-732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"PB","title":["Sacubitril\/valsartan versus angiotensin inhibitors and arrhythmia endpoints in heart failure with reduced ejection fraction"],"prefix":"10.1016","volume":"2","author":[{"given":"Amanda D.F.","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilson C.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caique M.P.","family":"Ternes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhanderson","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra V.","family":"Chaparro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Goldberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hroo.2021.09.009_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10840-019-00623-x","article-title":"Heart failure as a substrate and trigger for ventricular tachycardia","volume":"56","author":"Alvarez","year":"2019","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.hroo.2021.09.009_bib2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/01.RES.0000145047.14691.db","article-title":"What causes sudden death in heart failure?","volume":"95","author":"Tomaselli","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.hroo.2021.09.009_bib3","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2021.09.009_bib4","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jacc.2020.11.022","volume":"77","author":"Maddox","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.09.009_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012272","article-title":"Effects of the angiotensin-receptor neprilysin inhibitor on cardiac reverse remodeling: meta-analysis","volume":"8","author":"Wang","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hroo.2021.09.009_bib6","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hroo.2021.09.009_bib7","unstructured":"Higgins JPT, Thomas J, Chandler J, et al. Cochrane handbook for systematic reviews of interventions version 6.2 (updated February 2021). Cochrane, 2021. Available at: www.training.cochrane.org\/handbook. Accessed October 16, 2021."},{"key":"10.1016\/j.hroo.2021.09.009_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jebm.12141","article-title":"The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review","volume":"8","author":"Zeng","year":"2015","journal-title":"J Evid Based Med"},{"key":"10.1016\/j.hroo.2021.09.009_bib9","unstructured":"A multi-center, prospective, randomized, double-blind study to assess the impact of sacubitril\/valsartan vs. enalapril on daily physical activity using a wrist worn actigraphy device in adult chronic heart failure patients (OUTSTEP-HF), 2019. [E-pub ahead of print]. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT02900378. Accessed October 16, 2021."},{"key":"10.1016\/j.hroo.2021.09.009_bib10","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1001\/jama.2019.12843","article-title":"Effect of sacubitril-valsartan vs enalapril on aortic stiffness in patients with heart failure and reduced ejection fraction: a randomized clinical trial","volume":"322","author":"Desai","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.hroo.2021.09.009_bib11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/jamacardio.2019.4665","article-title":"Initiation of angiotensin-neprilysin inhibition after acute decompensated heart failure: secondary analysis of the open-label extension of the PIONEER-HF trial","volume":"5","author":"DeVore","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hroo.2021.09.009_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.hrthm.2017.11.012","article-title":"Effects of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable defibrillator devices","volume":"15","author":"de Diego","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.09.009_bib13","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3390\/jcm8101582","article-title":"Impact of sacubitril\/valsartan on the long-term incidence of ventricular arrhythmias in chronic heart failure patients","volume":"8","author":"El-Battrawy","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.hroo.2021.09.009_bib14","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3390\/jcm8060869","article-title":"Antiarrhythmic effect of sacubitril-valsartan: cause or consequence of clinical improvement?","volume":"8","author":"Valentim Gon\u00e7alves","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.hroo.2021.09.009_bib15","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1007\/s00392-019-01440-y","article-title":"Sacubitril\/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction","volume":"108","author":"Martens","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.hroo.2021.09.009_bib16","first-page":"91","article-title":"Impact of sacubitril-valsartan compared to angiotensin inhibition on ventricular tachycardia burden in heart failure patients with reduced ejection fraction and implantable defibrillator","volume":"21","author":"Polymeropoulos","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hroo.2021.09.009_bib17","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ejhf.799","article-title":"Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides","volume":"19","author":"D'Elia","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hroo.2021.09.009_bib18","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jchf.2019.05.013","article-title":"Neurohormonal antagonists are preferred to an implantable cardioverter-defibrillator in preventing sudden death in heart failure","volume":"7","author":"Packer","year":"2019","journal-title":"JACC Heart Fail"},{"issue":"Suppl 1","key":"10.1016\/j.hroo.2021.09.009_bib19","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1016\/j.ihj.2018.01.002","article-title":"Sacubitril\/valsartan: a novel angiotensin receptor-neprilysin inhibitor","volume":"70","author":"Dargad","year":"2018","journal-title":"Indian Heart J"},{"key":"10.1016\/j.hroo.2021.09.009_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.repc.2018.10.011","article-title":"Neurohormonal modulation: the new paradigm of pharmacological treatment of heart failure","volume":"38","author":"Silva-Cardoso","year":"2019","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.hroo.2021.09.009_bib21","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41569-020-0394-8","article-title":"Intracellular calcium leak in heart failure and atrial fibrillation: a unifying mechanism and therapeutic target","volume":"17","author":"Dridi","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hroo.2021.09.009_bib22","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00424-014-1469-3","article-title":"Ca handling during excitation-contraction coupling in heart failure","volume":"466","author":"Zima","year":"2014","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.hroo.2021.09.009_bib23","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1002\/ehf2.12918","article-title":"Sacubitrilat reduces pro-arrhythmogenic sarcoplasmic reticulum Ca(2+) leak in human ventricular cardiomyocytes of patients with end-stage heart failure","volume":"7","author":"Eiringhaus","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.hroo.2021.09.009_bib24","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1042\/BST0350952","article-title":"Sarcoplasmic reticulum calcium leak and cardiac arrhythmias","volume":"35","author":"Chelu","year":"2007","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.hroo.2021.09.009_bib25","doi-asserted-by":"crossref","first-page":"7906","DOI":"10.1073\/pnas.0602133103","article-title":"Stabilization of cardiac ryanodine receptor prevents intracellular calcium leak and arrhythmias","volume":"103","author":"Lehnart","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hroo.2021.09.009_bib26","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/CIRCHEARTFAILURE.109.865279","article-title":"Calcium\/calmodulin-dependent protein kinase II contributes to cardiac arrhythmogenesis in heart failure","volume":"2","author":"Sag","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hroo.2021.09.009_bib27","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/CIRCRESAHA.113.301651","article-title":"Mechanisms of altered Ca2\u207a handling in heart failure","volume":"113","author":"Luo","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.hroo.2021.09.009_bib28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/CIRCULATIONAHA.118.034755","article-title":"Is sacubitril\/valsartan (also) an antiarrhythmic drug?","volume":"138","author":"Sarrias","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.09.009_bib29","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.1038\/s41598-019-42113-0","article-title":"Angiotensin receptor neprilysin inhibitor attenuates myocardial remodeling and improves infarct perfusion in experimental heart failure","volume":"9","author":"Pfau","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.hroo.2021.09.009_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002744","volume":"9","author":"Solomon","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hroo.2021.09.009_bib31","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1093\/eurheartj\/ehv186","article-title":"Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients","volume":"36","author":"Desai","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2021.09.009_bib32","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/HCO.0000000000000710","article-title":"The risk and prevention of sudden death in patients with heart failure with reduced ejection fraction","volume":"35","author":"Davis","year":"2020","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.hroo.2021.09.009_bib33","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jacc.2018.11.042","article-title":"Effects of sacubitril\/valsartan on biomarkers of extracellular matrix regulation in patients with HFrEF","volume":"73","author":"Zile","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.09.009_bib34","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jcmg.2012.12.008","article-title":"Dyssynchrony and the risk of ventricular arrhythmias","volume":"6","author":"Kutyifa","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hroo.2021.09.009_bib35","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.hrthm.2011.04.015","article-title":"Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival","volume":"8","author":"Hayes","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.09.009_bib36","doi-asserted-by":"crossref","first-page":"987","DOI":"10.33963\/KP.14972","volume":"77","author":"Grabowski","year":"2019","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.hroo.2021.09.009_bib37","first-page":"270","article-title":"A systematic review and meta-analysis of the association between implantable cardioverter-defibrillator shocks and long-term mortality","volume":"31","author":"Proietti","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hroo.2021.09.009_bib38","doi-asserted-by":"crossref","first-page":"110","DOI":"10.15420\/AER.2016.12.2","article-title":"The significance of shocks in implantable cardioverter defibrillator recipients","volume":"5","author":"Li","year":"2016","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"10.1016\/j.hroo.2021.09.009_bib39","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2013.04.083","article-title":"Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study","volume":"62","author":"Powell","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.09.009_bib40","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.jacc.2021.03.329","article-title":"Survival after implantable cardioverter-defibrillator shocks","volume":"77","author":"Akta\u015f","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.09.009_bib41","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.hrthm.2021.03.028","article-title":"Association of SGLT2 inhibitors with arrhythmias and sudden cardiac death in patients with type 2 diabetes or heart failure: a meta-analysis of 34 randomized controlled trials","volume":"18","author":"Fernandes","year":"2021","journal-title":"Heart Rhythm"}],"container-title":["Heart Rhythm O2"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501821001914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501821001914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:27:19Z","timestamp":1762993639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666501821001914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2666501821001914"],"URL":"https:\/\/doi.org\/10.1016\/j.hroo.2021.09.009","relation":{},"ISSN":["2666-5018"],"issn-type":[{"value":"2666-5018","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sacubitril\/valsartan versus angiotensin inhibitors and arrhythmia endpoints in heart failure with reduced ejection fraction","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm O2","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hroo.2021.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Heart Rhythm Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}